Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells

Breast Cancer Research and Treatment

Volumn 110, Issue 2, 2008, Pages 257-268

  Xie, J W ^a   Haslam, S Z ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Cyclin D1; Estrogen; Estrogen receptor; Extracellular matrix; Laminin; MCF 7; Rac1

Indexed keywords

ANTIESTROGEN; COLLAGEN TYPE 1; CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; INTEGRIN; LAMININ; MOLECULAR MARKER; PROTEIN C JUN; PROTEIN CDC42; RAC1 PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER SURVIVAL; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; CYCLIN D1; ESTROGENS; EXTRACELLULAR MATRIX; HUMANS; LAMININ; MODELS, BIOLOGICAL; RAC GTP-BINDING PROTEINS; RAC1 GTP-BINDING PROTEIN; RECEPTORS, ESTROGEN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 44849124445     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9719-0     Document Type: Article

References (34)

1. Martin LM, le Pechoux C, Calitchi E et al (1994) Management of breast cancer in the elderly. Eur J Cancer 30A:590-596
2. Osborne CK, Coronado E, Allred DC et al (1991) Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J Natl Cancer Inst 83:1477-1482
3. Woodward TL, Lu H, Haslam SZ (2000) Laminin inhibits estrogen action in human breast cancer cells. Endocrinology 141:2814-2821
4. Giancotti FG (2000) Complexity and specificity of integrin signalling. Nat Cell Biol 2:E13-E14
5. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285:1028-1032
6. Giancotti FG (2003) A structural view of integrin activation and signaling. Dev Cell 4:149-151
7. Mettouchi A, Klein S, Guo W et al (2001) Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol Cell 8:115-127
8. Zahir N, Lakins JN, Russell A et al (2003) Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 163:1397-1407
9. Xie J, Haslam SZ (1997) Extracellular matrix regulates ovarian hormone-dependent proliferation of mouse mammary epithelial cells. Endocrinology 138:2466-2473
10. Stofega MR, Sanders LC, Gardiner EM et al (2004) Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions. Mol Biol Cell 15:2965-2977
11. Jeong HW, Nam JO, Kim IS (2005) The COOH-terminal end of R-Ras alters the motility and morphology of breast epithelial cells through Rho/Rho-kinase. Cancer Res 65:507-515
12. Zhang S, Li X, Burghardt R et al (2005) Role of estrogen receptor (ER) alpha in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells. J Mol Endocrinol 35:433-447
13. Dhar K, Banerjee S, Dhar G et al (2007) Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells. Cancer Res 67:1520-1526
14. Lin CW, Yang LY, Shen SC et al (2007) IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells. J Cell Physiol 212:666-674
15. Wennerberg K, Der CJ (2004) Rho-family GTPases: it's not only Rac and Rho (and I like it). J Cell Sci 117:1301-1312
16. Mira JP, Benard V, Groffen J et al (2000) Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci U S A 97:185-189
17. Gutzman JH, Nikolai SE, Rugowski DE et al (2005) Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos. Mol Endocrinol 19:1765-1778
18. Frost JA, Steen H, Shapiro P et al (1997) Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. Embo J 16:6426-6438
19. Lu C, Shen Q, DuPre E et al (2005) cFos is critical for MCF-7 breast cancer cell growth. Oncogene 24:6516-6524
20. Albanito L, Madeo A, Lappano R et al (2007) G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-1866
21. Castoria G, Migliaccio A, Bilancio A et al (2001) PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. Embo J 20:6050-6059
22. Liu H, Radisky DC, Wang F et al (2004) Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 164:603-612
23. Migliaccio A, Castoria G, Di Domenico M et al (2002) Src is an initial target of sex steroid hormone action. Ann N Y Acad Sci 963:185-190
24. Noel A, Simon N, Raus J et al (1992) Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem Pharmacol 43:1263-1267
25. Schnelzer A, Prechtel D, Knaus U et al (2000) Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19:3013-3020
26. Chan AY, Coniglio SJ, Chuang YY et al (2005) Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 24:7821-7829
27. Baugher PJ, Krishnamoorthy L, Price JE et al (2005) Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Breast Cancer Res 7:R965-974
28. Zuo Y, Shields SK, Chakraborty C (2006) Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase. Biochem Biophys Res Commun 351:361-367
29. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659
30. Ronnov-Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76:69-125
31. Rabinovitz I, Mercurio AM (1996) The integrin alpha 6 beta 4 and the biology of carcinoma. Biochem Cell Biol 74:811-821
32. Larbre H, Loemba L, Deltour G (1989) [Assay of the laminin P1 using a radioimmunologic technic: applications in oncology]. Bull Cancer 76:947-953
33. Cress AE, Rabinovitz I, Zhu W et al (1995) The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev 14:219-228
34. Ziober BL, Lin CS, Kramer RH (1996) Laminin-binding integrins in tumor progression and metastasis. Semin Cancer Biol 7:119-128